Compound Detail
CHEMBL284092
GEPIRONE 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
Basic Information
| ChEMBL ID | CHEMBL284092 |
| Name | GEPIRONE |
| Phase | Approved |
| Structure Type | MOL |
| InChI Key | QOIGKGMMAGJZNZ-UHFFFAOYSA-N |
| Therapeutic | ✓ Yes |
5
Targets
11
Activities
4
Assay Types
2
PK Parameters
20
Publications
8
Known Names
2
Indications
1
Mechanisms
Molecular Properties
359.5
MW (Da)
1.55
ALogP
6
HBA
0
HBD
69.6
PSA (Ų)
0.57
QED
0
Ro5 Violations
6
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| First Approval | 2023 |
| Availability | Discontinued |
| Chirality | Achiral |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Serotonin 1a (5-HT1a) receptor agonist | AGONIST | 5-hydroxytryptamine receptor 1A | ✓ | ✓ |
Indications
Cocaine-Related Disorders Depressive Disorder
ATC Classification
N06AX19
gepirone
Level 1: NERVOUS SYSTEM
Level 2: PSYCHOANALEPTICS
Activity Summary
Ki 8 meas. best 7.89
EC50 1 meas. best 6.54
IC50 1 meas. best 6.94
Kd 1 meas. best 7.1
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| 5-hydroxytryptamine receptor 1A CHEMBL214 | Ki | 7.89 | 7.695 | 13.0 | 2 |
| 5-hydroxytryptamine receptor 1A CHEMBL273 | Ki | 7.5 | 7.33 | 31.8 | 2 |
| D(2) dopamine receptor CHEMBL217 | Ki | 7.24 | 6.305 | 58.0 | 2 |
| 5-hydroxytryptamine receptor 1A CHEMBL214 | Kd | 7.1 | 7.1 | 79.4 | 1 |
| 5-hydroxytryptamine receptor 1A CHEMBL214 | IC50 | 6.94 | 6.94 | 114.0 | 1 |
| 5-hydroxytryptamine receptor 1A CHEMBL214 | EC50 | 6.54 | 6.54 | 288.0 | 1 |
| Adrenergic receptor alpha-1 CHEMBL1907610 | Ki | 5.62 | 5.62 | 2400.0 | 1 |
| 5-hydroxytryptamine receptor 2A CHEMBL224 | Ki | 5.44 | 5.44 | 3630.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| T1/2 | 0.505 | hr | Homo sapiens |
| T1/2 | 6.0 | hr | Homo sapiens |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 15646539 | 10.1016/s0399-8320(04)95062-2 | Unchecked | 11 |
| 15646539 | 10.1016/s0399-8320(04)95062-2 | NON-PROTEIN TARGET | 8 |
| 20014752 | 10.1021/tx900326k | Hepatotoxicity | 3 |
| 16722631 | 10.1021/jm0508641 | 5-hydroxytryptamine receptor 1A | 3 |
| - | 10.6019/CHEMBL4651402 | SARS-CoV-2 | 2 |
| 1535661 | 10.1021/jm00091a004 | 5-hydroxytryptamine receptor 1A | 2 |
| 6131130 | 10.1021/jm00356a014 | Dopamine receptor | 2 |
| 6131130 | 10.1021/jm00356a014 | Rattus norvegicus | 2 |
| 3172131 | 10.1021/jm00118a018 | 5-hydroxytryptamine receptor 1A | 2 |
| 16722631 | 10.1021/jm0508641 | Adrenergic receptor alpha-1 | 1 |
| 28850227 | 10.1021/acs.jmedchem.7b00315 | 5-hydroxytryptamine receptor 2A | 1 |
| 19754201 | 10.1021/jm901096y | 5-hydroxytryptamine receptor 1A | 1 |
| 16722631 | 10.1021/jm0508641 | Homo sapiens | 1 |
| 16722631 | 10.1021/jm0508641 | Dopamine D2 receptor and serotonin 1a receptor | 1 |
| 16722631 | 10.1021/jm0508641 | D(2) dopamine receptor | 1 |
| 16722631 | 10.1021/jm0508641 | Unchecked | 1 |
| 6131130 | 10.1021/jm00356a014 | Adrenergic receptor alpha-1 | 1 |
| 1535661 | 10.1021/jm00091a004 | ADMET | 1 |
| 1535661 | 10.1021/jm00091a004 | No relevant target | 1 |
| 15026055 | 10.1016/j.bmcl.2004.01.045 | ADMET | 1 |
Data from ChEMBL 36 via Core Engine